HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cancer incidence and mortality during the intervention and postintervention periods of the Women's Health Initiative dietary modification trial.

AbstractBACKGROUND:
The Women's Health Initiative (WHI) low-fat (20% kcal) dietary modification (DM) trial (1993-2005) demonstrated a nonsignificant reduction in breast cancer, a nominally significant reduction in ovarian cancer, and no effect on other cancers (mean 8.3 years intervention). Consent to nonintervention follow-up was 83% (n = 37,858). This analysis was designed to assess postintervention cancer risk in women randomized to the low-fat diet (40%) versus usual diet comparison (60%).
METHODS:
Randomized, controlled low-fat diet intervention for prevention of breast and colorectal cancers conducted in 48,835 postmenopausal U.S. women, ages 50 to 79 years at 40 U.S. sites. Outcomes included total invasive cancer, breast cancer, and colorectal cancer, and cancer-specific and overall mortality.
RESULTS:
There were no intervention effects on invasive breast or colorectal cancer, other cancers, or cancer-specific or overall mortality during the postintervention period or the combined intervention and follow-up periods. For invasive breast cancer, the hazard ratios (HR) and 95% confidence interval (CI) were 0.92 (0.84-1.01) during intervention, 1.08 (0.94-1.24) during the postintervention period, and 0.97 (0.89-1.05) during cumulative follow-up. A reduced risk for estrogen receptor positive/progesterone receptor-negative tumors was demonstrated during follow-up. In women with higher baseline fat intake (quartile), point estimates of breast cancer risk were HR, 0.76 (95% CI, 0.62-0.92) during intervention versus HR, 1.11 (95% CI, 0.84-1.4) during postintervention follow-up (Pdiff = 0.03).
CONCLUSIONS:
Dietary fat intake increased postintervention in intervention women; no long-term reduction in cancer risk or mortality was shown in the WHI DM trial.
IMPACT:
Dietary advisement to reduce fat for cancer prevention after menopause generally was not supported by the WHI DM trial.
AuthorsCynthia A Thomson, Linda Van Horn, Bette J Caan, Aaron K Aragaki, Rowan T Chlebowski, JoAnn E Manson, Thomas E Rohan, Lesley F Tinker, Lewis H Kuller, Lifang Hou, Dorothy S Lane, Karen C Johnson, Mara Z Vitolins, Ross L Prentice
JournalCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (Cancer Epidemiol Biomarkers Prev) Vol. 23 Issue 12 Pg. 2924-35 (Dec 2014) ISSN: 1538-7755 [Electronic] United States
PMID25258014 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural)
Copyright©2014 American Association for Cancer Research.
Topics
  • Aged
  • Feeding Behavior (physiology)
  • Female
  • Humans
  • Incidence
  • Middle Aged
  • Neoplasms (epidemiology, mortality)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: